Demystifying COGS Pharma Competitive Intelligence
How to Uncover Cost of Goods Sold (COGS) Insights with Pharma Competitive Intelligence COGS, aka the cost of goods sold, is one of the key intelligence questions that frequently emerge…
Looking beyond Generics in Commercial Due Diligence of Generics Pharmaceutical Businesses
How to Conduct Robust Commercial Due Diligence by Looking Beyond Generics in Pharma Businesses Investors need to look beyond generics in the pharmaceutical commercial due diligence (CDD) for investment in…
Anticipating Future with Pharma and Diagnostics Competitive Intelligence
Pharma and Diagnostics Competitive Intelligence: How to Anticipate Future Competitive intelligence (CI) is a commonly used decision-making tool in the pharmaceutical industry for seeking competitive advantage. It is often forward-looking…
Determining True Addressable Market in Healthcare and Life Sciences Commercial Due Diligence
How to Accurately Assess the True Addressable Market in Healthcare and Life Sciences Due Diligence Determining the appropriate addressable market is often one of the critical success factors in commercial…
Terminal Value Issues in Valuation of Pharmaceutical Assets
How to Address Terminal Value Challenges in Pharmaceutical Asset Valuation Several stakeholders who have an interest in pharmaceutical assets employ a multitude of methods to conduct valuations. Among various valuation…
Digital Health and IoT are attractive opportunities for Life Sciences Investors and Pharmaceutical Companies
Win-win Investment Opportunities in Digital Health and IoT for Life Sciences Investors and Pharma Industry Digital Health and IoT are attractive opportunities for Life Sciences Investors and Pharmaceutical companies. The…
Key Drivers of Biotechnology Valuation
A deep understanding of the key biotechnology valuation drivers is critical for those who have an interest in biotech assets and businesses- read how to conduct pharma and biotech valuation…
Optimal Strategy for Pharmaceutical Asset Commercialization
A Value-Driven Commercialization Strategy for Pharmaceutical Assets An optimal commercialization strategy for pharmaceutical and biotechnology companies is vital for the value maximization of the company. Early-stage, as well as developed…
Key To Success in Medical Devices Competitive Intelligence
Effective Competitive Intelligence Strategies for Gaining an Edge in the Medical Devices Industry Medical devices are an important part of the healthcare industry, with tremendous potential to improve patient outcomes…